The angiotensin II antagonist, irbesartan, significantly reduces arterial pressure and proteinuria in children with chronic kidney disease, researchers report.
“Our report in preschool-aged children, older children and male adolescents with chronic kidney diseases given irbesartan confirms the results of large trials in hypertensive adults treated with this drug,” Dr. Mario G. Bianchetti told Reuters Health.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!